|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N 33/569 | |
| G01N 33/577 | |||
| C12N 15/03 |
| (11) | Patento numeris | 2823312 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13710328.9 |
| Europos patento paraiškos padavimo data | 2013-03-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-01-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-08-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2013/054670 |
| Data | 2013-03-08 |
| (87) | Numeris | WO 2013/132040 |
| Data | 2013-09-12 |
| (30) | Numeris | Data | Šalis |
| 201261608293 P | 2012-03-08 | US |
| (72) |
GIULIANI, Marzia, IT
MORI, Elena, IT
|
| (73) |
GlaxoSmithKline Biologicals SA,
Rue de l`Institut 89, 1330 Rixensart,
BE
|
| (54) | IN VITRO POTENCY ASSAY FOR PROTEIN-BASED MENINGOCOCCAL VACCINES |
| IN VITRO POTENCY ASSAY FOR PROTEIN-BASED MENINGOCOCCAL VACCINES |